DABUR vs MARICO
Side-by-side comparison of Dabur India Ltd. and Marico Ltd.. Descriptive only — not investment advice.
Dabur India Ltd.
FMCG
Quality Score: 64/100
Marico Ltd.
FMCG
Quality Score: 71/100
At a glance
| Metric | DABUR | MARICO |
|---|---|---|
| Quality Score | 64/100 | 71/100 |
| P/E (trailing) | 40.7 | 58.6 |
| Forward P/E | 33.0 | 43.8 |
| ROE | +16.2% | — |
| Profit margin | +14.4% | +13.2% |
| Debt-to-equity | 10.91 | 12.39 |
| Dividend yield | +1.94% | +0.46% |
| 1Y price return | -15.6% | +21.4% |
| From 52w high | -25.1% | -2.9% |
| Analyst rating1 = Strong Buy, 5 = Strong Sell | 2.38 | 1.68 |
Highlighted value = better on the metric (lower for P/E, D/E, drawdown, analyst rating; higher elsewhere). Descriptive only.
Snapshots
Dabur trades at ₹424.60, down 15.64% over the past year and 25.06% below its 52-week high, sitting below both its 50-DMA (₹427.85) and 200-DMA (₹468.53). Q1 net profit rose 15% to ₹591 crore on 10.5% revenue growth, with the India FMCG business up 9.5% and management citing rural demand ahead of urban. The stock carries a PE of 40.68 — the 2nd-lowest among 6 FMCG peers tracked — and a mean analyst rating of 2.37838 across 37 analysts (1–5 scale, lower = more constructive).
Marico trades at Rs 863.50, up 21.38% over the past year and 3.89% over three months, sitting 2.88% below its 52-week high with RSI at 54 (neutral) and price above both its 50-day (Rs 837.22) and 200-day (Rs 777.21) moving averages. Q1 FY27 net profit rose 27% YoY to Rs 652 crore on strong domestic volume growth, part of a stated push toward Rs 15,000 crore in revenue by FY27-end. Trailing PE of 58.60x sits above the tracked FMCG peer median of roughly 55.2x, while forward PE of 43.84x reflects consensus expectations for continued earnings growth.
Pros
- ✓Q1 net profit grew 15% YoY to ₹591 crore on 10.5% revenue growth, with the India FMCG business up 9.5% and rural demand cited as ahead of urban.
- ✓News sentiment across the 8 most recent tracked items is 7 positive, 1 neutral, and 0 negative.
- ✓Trades at a PE of 40.68, the 2nd-lowest (cheapest) of 6 names in the FMCG peer set, behind only ITC (17.34).
- ✓Five-year record shows ROE above 15% in 4 of the years measured and positive free cash flow in 4 of the years measured, with a flat debt trend and a consistency score of 53.
- ✓ROE was above 15% in 4 of the last 5 years, with a multi-year persistence consistencyScore of 75.
- ✓Debt-to-equity of roughly 0.12x is well below typical FMCG leverage levels, with a flat multi-year debt trend.
- ✓Q1 FY27 net profit rose 27% YoY to Rs 652 crore on strong domestic volume growth, beating estimates.
- ✓Composite quality score of 49 ranks 2nd of 6 tracked FMCG peers, trailing only Nestle India (57).
Cons
- ✗Price of ₹424.60 sits below both the 50-DMA (₹427.85) and 200-DMA (₹468.53), down 15.64% over the trailing year and 25.06% off its 52-week high.
- ✗Debt-to-equity of 10.907 is materially above the asset-light balance sheets typical of FMCG peers such as HINDUNILVR, NESTLEIND, and BRITANNIA.
- ✗Quality score of 47 ranks 3rd of 6 in the peer set, behind NESTLEIND (57) and BRITANNIA (50); five-year revenue growth of 7.3% is modest.
- ✗Peer priceChange1Y data is unavailable for all 5 comparators, limiting the ability to gauge 1-year relative price performance within the sector.
- ✗Trailing PE of 58.60x sits above the FMCG peer-group median (~55.2x), and free cash flow was negative in 1 of the last 5 measured years.
- ✗Forward PE of 43.84x is about 25% below trailing PE, implying the market has priced in continued earnings acceleration toward the stated Rs 15,000-crore FY27 revenue goal.
- ✗Current-period ROE is unavailable (null) in the latest fundamentals pull, despite the multi-year tracker showing ROE above 15% in 4 of the last 5 years.
- ✗ROE and 1-year price-change data are unavailable (null) for all 5 tracked FMCG peers, limiting cross-peer comparison to PE and quality score alone.
Want the full analysis for either stock?
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Comparison reflects current public data; consult a registered adviser before any investment decision.